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HIGHLIGHTS 
 Natural uranium is cytotoxic towards dopaminergic cells but only at high concentration, not 
relevant for human exposure 
 
 Uranium limited cytotoxicity is related to its low intracellular accumulation 
 
 Uranium is located in defined cytoplasmic regions suggesting its accumulation within cell 
organelles yet to be determined 
 
 Monoamine oxidase B gene expression is decreased following natural uranium exposure 
even at non cytotoxic exposure levels. 
 
ABSTRACT 
Natural uranium is an ubiquitous element present in the environment and human exposure to low 
levels of uranium is unavoidable. Although the main target of acute uranium toxicity is the kidney, 
some concerns have been recently raised about the effect chronic exposure to low levels of uranium 
on neurological functions. Studies of uranium neurotoxicity on animal models have shown subtle 
changes of behavior such as increased locomotor activity, perturbation of the sleep-wake cycle, 
decreased memory, and increased anxiety. Only very few studies have addressed the molecular 
mechanisms of uranium neurotoxicity indicating that the cholinergic and dopaminergic systems could 
be altered. The main objective of this study was to investigate the mechanisms of uranium toxicity on 
human SH-SY5Y differentiated into a dopaminergic phenotype as verified by tyrosine hydroxylase 
expression. SH-SY5Y differentiated cells were exposed to 1, 10, 125 and 250 µM of natural uranium. 
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First the cytotoxicity of uranium was evaluated using ATP fluorescence assays. Our results show that 
uranium cytotoxicity only occurs at relatively high exposure concentrations (> 125 µM), far from the 
expected values for uranium in the blood even after occupational exposure (< 1 µM). Then uranium 
quantitative subcellular distribution was investigated by means of micro-PIXE (Particle Induced X-ray 
Emission). The subcellular element imaging revealed that uranium was present in defined perinuclear 
regions of the cytoplasm but never in the nucleus of the differentiated cells. Quantitative analysis of 
uranium intracellular content evidenced a very limited uranium accumulation at low levels of 
exposure (1 and 10 µM) and a less controlled incorporation resulting in uranium content at higher 
levels of exposure, when cytotoxic effects are observed (125 ad 250 µM). Finally the expression of 
genes related to the dopaminergic phenotype was determined using quantitative real time RT-PCR. 
The expression of monoamine oxidase B gene is statistically significantly decreased after exposure to 
uranium while other genes related to the dopamine system are not modified. This result together 
with published data indicate that the catabolism of dopamine could be a selective target for uranium 
neurotoxic effects. 
 
Keywords: uranium, neurotoxicity, in vitro, subcellular distribution, dopaminergic cells, monoamine 
oxidase B. 
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1. Introduction  
Uranium is a natural radioelement, weakly radioactive and toxic at high concentrations for humans, 
whose toxicity is essentially chemical. Uranium occurs naturally in the environment, existing in nearly 
all rocks and soils with a typical natural abundance of 2 to 4 µg.g-1. This ubiquitous presence results in 
continuous human exposure to low uranium concentrations mainly through ingestion (Keith et al., 
2008; ATSRD, 2013). Intake from water and food approximate 0.9 – 1.5 µg/day for most of the 
population. Higher exposure levels may be found in geographical areas with elevated levels of 
naturally occurring uranium, increasing uranium content in food, or in the water especially when 
ground water is used for drinking. In some regions of the world, uranium in ground water can reach 
values most above the 30 µg.L-1 WHO recommended guideline for drinking water quality (Frisbie et 
al., 2009; WHO, 2011). Moreover, the WHO recommended guideline for uranium in drinking water is 
only provisional and a matter of debate since it might not be fully protective for the general 
population (Frisbie et al., 2013, Ansoborlo et al., 2015). The highest human exposures are found in 
occupational settings, in uranium milling and processing industries, or for people working with 
phosphate fertilizers. Recently human exposure also involves military use of depleted uranium 
weapons. 
In case of high uranium exposure, the main target of uranium toxicity in human are the kidneys. Less 
severe effects are however observed on the liver, lungs, bones, reproductive and nervous systems 
(Keith et al., 2008; ATSRD, 2013). In the last few years several studies have clearly pointed out that 
the brain is a sensitive target for uranium toxicity (reviewed in Dinocourt et al., 2015). Uranium 
exposure induces neurobehavioral changes such as increased locomotor activity, perturbation of the 
sleep-wake cycle, decreased memory, and increased anxiety on animal models. The mechanisms by 
which uranium induces neurological alterations are not fully known. Changes in levels of 
neurotransmitters and their metabolites, such as acetylcholinesterase activity and monoamine 
metabolism have been observed in animal brains after exposure to uranium (Bussy et al., 2006; 
Barber et al., 2007; Briner et al., 2008; Bensoussan et al., 2009). Further studies are needed to better 
understand the mechanisms of action for uranium-induced neurological effects. Such data are 
required to evaluate whether long-term exposure to uranium concentrations could affect 
neurological functions in humans especially to populations exposed to excessive uranium in the 
drinking water or in the food. 
The aim of this study was to investigate the mechanisms of neurotoxicity of natural uranium on 
human dopaminergic cells. The cytotoxic concentrations were evaluated, as well as the intracellular 
distribution of uranium and the expression of genes involved in monoamine metabolism. 
Most of the existing studies on uranium-induced toxicity involved rodent animal models and data on 
uranium toxicity thresholds and on molecular mechanisms of neurotoxicity in human are still scarce. 
Here we selected a human cell line, SH-SY5Y as study model. Human SH-SY5Y cells are frequently 
used as in vitro neuronal model as these cells may acquire a neuronal dopaminergic phenotype after 
a differentiation step (Presgraves et al., 2004). Using this cellular model we have recently evidenced 
the isotopic fractionation of uranium suggesting the existence of a high affinity transporter protein 
for uranium uptake (Paredes et al., 2016). In the present study we addressed the question of 
uranium intracellular distribution using Particle Induced X-ray Emission (PIXE) chemical element 
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imaging. At high exposure concentrations uranium is known to form insoluble precipitates with 
needle shapes located in intracellular vesicles as observed with different cellular models (Carrière et 
al., 2006 and 2008; Pierrefite-Carle et al., 2015). Only very few studies have addressed the 
intracellular distribution of uranium at lower exposure concentrations before it forms precipitates. 
These studies have brought controversial results since in one hand, uranium was found only in the 
nucleus of the cells (Rouas et al. 2010; Guéguen et al., 2015), while in the other hand uranium was 
never found in the nucleus but in defined regions of the cytoplasm (Homma-Takeda et al., 2015). 
Only one study reported uranium distribution in neuron-like cells (Rouas et al., 2010). In addition, by 
using reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) our study brings 
original results on the interaction of uranium with expression of genes related to the dopaminergic 
pathway in human cells. 
 
2. Material and methods 
 
2.1. Reagents and solutions 
Eagle’s minimum essential medium (EMEM, 30-2003; ATCC), F12 medium (21765-029; Life 
Technologies), FBS (30- 2020; ATCC), and penicillin/streptomycin (15070-063; Gibco-Thermo Fisher 
Scientific) solutions were used to prepare the culture medium for cell growing and exposure 
experiments. TrypLE Express 1×/EDTA (12605-010; Gibco-Thermo Fisher Scientific) was used for the 
trypsinization of cells. PBS (pH 7.4) free of CaCl2 and MgCl2 (10010-015; Gibco) was used to wash the 
cells after trypsinization. Retinoic acid (RA) and 12-O-tetradecanoylphorbol-13-acetate (TPA) used for 
cell differentiation were purchased from Sigma-Aldrich (R2625 and P8139, respectively). A 3-mg.mL−1 
RA solution was prepared in sterile dimethyl sulfoxide (DMSO, Sigma-Aldrich) under a nitrogen 
atmosphere in opaque tubes and stored at −80 °C. TPA was resuspended at 1 mg.mL−1 in sterile 
DMSO, and the solution was stored at −20 °C. 
2.2.  Cells and dopaminergic differentiation 
SH-SY5Y human neuroblastoma cells were purchased from ATCC USA (CRL-2266TM, Lot 59740436). 
Cells were cultured according to ATCC guidelines. The complete growth medium consisted in a 1:1 
mixture of Eagle's Minimum Essential Medium (EMEM, ATCC), and F12 Medium (Sigma), 
supplemented with 10% fetal bovine serum (FBS, ATCC), 100 μg/ml penicillin, 100 μg/ml 
streptomycin (Gibco). Complete growth medium was renewed every 3 to 4 days. Cells were cultured 
at 37°C in air with 5% carbon dioxide. SH-SY5Y cells were terminally differentiated into dopaminergic 
neuron-like cells according to the protocol of Presgraves et al. (2004), Table 1. In brief, one day after 
seeding at 25000 cells cm-2, cells were first treated with 10 µM RA (Sigma) during 2.5 days. Then the 
medium was renewed using fresh complete growth medium with 80 nM TPA (Sigma) and cells were 
cultured for 3.5 days. In order to control that the dopaminergic phenotype was correctly induced, the 
expression of tyrosine hydroxylase was evaluated by Western blot analysis.    
2.3. Western blot analysis of tyrosine hydroxylase 
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Western blots were performed as described earlier {Malard, 2009 #524}. After 7 days of 
differentiation, the cells were trypsinized, washed with PBS, then incubated with RIPA buffer (Santa 
Cruz) containing protease inhibitor cocktail tablet (Complete EDTA free TM Roche) and phosphatase 
inhibitor (Cocktail I and II, Sigma). The cellular extracts were lysed using a Dounce homogenizer (20 
strokes), incubated on ice for 60 min, and then centrifuged at 16,000 g for 60 min. The protein 
content of the supernatants was determined with the Coomassie Protein Assay (Thermo Scientifc). 
Proteins were separated on a 4-12% NuPAGE® Bis-Tris gel (Invitrogen) in a MOPS/SDS Running Buffer 
(Invitrogen) at 200 V. Proteins from the gel were electroblotted on a 0.45 µm PVDF membrane 
(Thermo scientific) using a semi-dry electroblot system (Biometra). After a saturation step in milk 5%, 
the membrane was incubated overnight at 4°C in a 5 % milk solution containing a polyclonal 
Antibody Rabbit anti-Tyrosine Hydroxylase (1/1000, cat# AB152, Millipore). Primary antibody was 
then detected using an anti Rabbit HRP (1/10000, Sigma; A6154). A mouse monoclonal anti-human 
actin from Sigma ref A3854 was used as a control at 1/25000. The signals were revealed using the 
Western Chemiluminescent HRP Substrate from Millipore. 
2.4. Preparation of the uranium exposure solution 
In-house (Laboratoire de développement Analytique, Nucléaire, Isotopique et Elémentaire (LANIE), 
DEN, CEA Saclay) natural uranium oxide powder U3O8 was dissolved in 0.5 M ultrapure HNO3 (SCP 
Science) to obtain a stock solution at U concentration of 151 mM. Uranium concentration was 
determined by quadrupole Inductively Coupled Plasma Mass Spectrometry (ICP-MS, X7 Series; 
Thermo Fisher Scientific). The natural uranium stock solution was characterized by a δ238 value of 
+0.66 ± 0.12‰ (2σ, n = 7) relative to the certified n(238U)/n(235U) of IRMM-184 material. This  stock 
solution was diluted into a buffer, made of 0.1 mol.L-1 NaHCO3, 0.1 mol.L
-1 Na2CO3, 0.15 mol.L
-1 NaCl 
and 0.05 mol.L-1 Tris in ultrapure water, so as to obtain an intermediate uranium solution with a pH 
compatible with cell culture experiments (pH = 8-8.5).  This dilution was performed with a ratio of 1:5 
v/v to reach a U concentration at 30 mM and by drop-by-drop addition of the U stock solution into 
the buffer to avoid U precipitation. Uranium was then stabilized in the intermediate solution under 
the tris-carbonate uranyl (VI) complexes [UO2(CO3)3]
4-, the most common uranium species found in 
biological fluids. U concentration in the intermediate solution was daily measured by ICPMS for one 
week showing that the intermediate solution was stable, without any uranium precipitate, at least 
during 7 days. The intermediate uranium solution was prepared the day before cell exposure and 
stored at room temperature (Table 1). 
2.5. Cell exposure to uranium 
The workflow for SH-SY5Y cell culture, differentiation and uranium exposure on sample holders for 
micro-PIXE experiments is summarized in Table 1. Sample holders for micro-PIXE consist in a thin (2 
µm) ultrapure polycarbonate film stretched over a plastic frame with a 5 mm x 5 mm window where 
cells are grown. Sample holders were sterilized in analytical grade ethanol, rinsed with ultrapure 
water and dried in sterile conditions. To enhance cell attachment, polycarbonate films were coated 
with a solution of 0.01 mg.mL-1 bovine serum albumin, 0.01 mg.mL-1 human fibronectin, and 0.03 
mg.mL-1 collagen type I (all products from Sigma) prepared in complete growth medium. Before cell 
seeding onto polycarbonate films, SH-SY5Y cells were first cultured for 10 days after thawing, in 
plastic flasks following standard methods as described before. At day 0 (Table 1), SH-SY5Y cells were 
harvested, counted, and 104 cells seeded onto each micro-PIXE sample holder. Cells were thereafter 
grown on polycarbonate films, differentiated with RA-TPA during 7 days and exposed to defined 
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concentrations of natural uranium for 7 days more. Uranium exposure solutions at 10, 125 and 250 
µM were selected according to the cytotoxicity assay results and prepared in complete cell growth 
medium by dilution of the 30 mM intermediate uranium solution. 
 
 Cell culture Seeding Cell differentiation Uranium exposure 
Day -10 0 1 3.5 6 7 10.5 14 
Task Thawing 
and 
standard 
cell culture 
Seed cells 
on poly-
carbonate 
membrane 
Add RA Add 
TPA 
Prepare 
uranium 
intermediate 
solution 
New medium 
with U 
New 
medium 
with U 
Live cell 
imaging and 
cryo-fixation 
 
Table 1. Protocol for SH-SY5Y cell culture, differentiation, and long-term exposure to natural 
uranium.  
2.6. Cytotoxicity studies 
The cytotoxic potential of uranium on differentiated SH-SY5Y cells was investigated by the CellTiter-
Glo® Luminescence Cell Viability Assay, an in vitro test that allows the measurement of the amount 
of intracellular ATP, which is directly linked to the number of metabolically active cells. Briefly, SH-
SY5Y cells were plated at the same density and conditions as described above. After differentiation, 
uranium toxicity was assessed between 0 µM to 500 µM and Triton 1% was used as a positive 
control. At the end of the exposure (7 days), The Promega CellTiter-Glo reagent was added and after 
a 20 min incubation, luminescence was measured on a luminescence plate reader (LumiStar, BMG) 
with a 5 s integrated reading. For each experimental point, four independent assays were carried 
out, each performed in sextuplate. Values were expressed as percentage of viability following the 
formula [(mean luminescence for a given sample condition/mean luminescence of unexposed cells)]. 
Data are presented as the mean ± SD. The Prism6 software (GraphPad software; La Jolla, CA, USA) 
allowed to calculate IC50 values, as well as IC25 and IC75. 
2.7. Sample preparation for micro-PIXE experiments 
The protocol for sample preparation was adapted from recently optimized methods for element 
imaging in single cells using micro-PIXE (Perrin et al., 2015). At day 14 (Table 1), SH-SY5Y terminally 
differentiated cells were labeled with a fluorescent nuclear dye, Hoechst 33342, in order to perform 
correlative imaging of nucleus position in single cells with element distributions, as previously 
described (Roudeau et al., 2014). Live cell imaging of the nuclear dye fluorescence was recorded with 
an epifluorescence microscope (Olympus BX51). Immediately after live cell microscopy, cells were 
rinsed with a 150 mM ammonium acetate buffer solution, pH 7.4, prepared in ultrapure water 
(Fisher) to remove traces of extracellular ions. Then cells were cryofixed by plunge freezing in 
isopentane chilled with liquid nitrogen down to -160°C, and freeze-dried at -90°C under primary 
vacuum (Christ Alpha 1-4 freeze drier). After 3 days of freeze drying, samples were slowly brought 
back to room temperature and ambient pressure. Samples were stored into a dessicator dry box until 
analysis.  
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2.8. Micro-PIXE analyses and data treatment 
Micro-PIXE analyses were carried out at AIFIRA facility (Applications Interdisciplinaires des Faisceaux 
d’Ions en Région Aquitaine) (Sorieul et al., 2014). AIFIRA ion beam facility is based on a 3.5 MV 
Singletron particle accelerator (HVEE, The Netherlands). The Singletron accelerator provided a 3.0 
MeV proton beam that was focused down to 800 nm beam size using the high spatial resolution 
beamline resulting in a 0.5 nA beam current. Uranium and the other chemical elements were 
mapped at the single cell level by performing micro-PIXE as recently reported (Ortega et al., 2014; 
Ortega et al., 2015). Single cells exposed to 0 (number of analyses, n=8), 1 µM (n=5), 10 µM (n=18), 
125 µM (n=26) and 250 µM (n=13) of uranium were analyzed. Quantification of element content in 
subcellular regions was obtained by extracting PIXE data from selected areas of the chemical maps 
(i.e. nucleus and cytoplasm). The exact location of the subcellular areas was defined thanks to the 
epifluorescence images evidencing the nucleus position in each cell following a correlative 
PIXE/epifluorescence microscopy approach (Roudeau et al., 2014). Calibration of the X-ray detectors 
was performed using MicromatterTM XRF calibration standards. Quantitative data treatment of PIXE 
spectra was performed using the GUPIXWIN software (Campbell et al., 2010). This software allows 
determining the element content and to precisely calculate detection limits. Charge normalization of 
PIXE data was obtained by performing simultaneously Rutherford Backscattering Spectrometry (RBS) 
following a methodology described in earlier publications (Carmona et al., 2008). The accuracy of the 
chemical elements quantification was checked by analyzing in the same conditions a 10 µm section 
of the European Reference Material EC681k, as already described (Perrin et al., 2015). Due to the low 
intracellular concentrations of uranium, long acquisition times were required to map uranium 
distributions in single cells, from 4 hours to 12 hours per cell for the lower uranium exposure 
condition. In total the micro-PIXE analyses exceeded 500 hours of beam time. 
2.9. RNA Extraction and RT-qPCR 
Total RNA was isolated using the Qiagen RNeasy miniprep kit (Qiagen) according to the 
manufacturer's instructions. RNA concentration and purity were determined by OD measurement on 
a nanodrop 2000 spectrophotometer (Thermo Ficher Scientific). We obtained A260/A280 ratios in 
the range 1.9-2.1. 1 µg of total RNA was retrotranscribed using the iScript™ Reverse Transcription 
Supermix for RT-qPCR (BIORAD) according manufacturer’s instructions. Primers used for qPCR 
(BIORAD) are described in Table XX, the primer’s efficiency was controlled by the supplier. The 
quantitative PCR was performed using SYBRgreen (Sso advanced universal SyBr Green supermix, 
Biorad, Hercules, CA) on a C1000 touch thermal cycler of Biorad (CFX96 Real Time System), according 
to the manufacturer's instructions, as follows: activation 2 min at 95°C, 40 cycles of denaturation (5 s 
at 95°C), 40 cycles of annealing (30 s at 60°C). Melting curve analysis was performed for verifying 
specificity of each primer after PCR, 5 s/step at 65°C-95°C (0.5°C increments), to ensure amplification 
specificity. Controls without template were included to verify that fluorescence was not 
overestimated from primer dimer formation or PCR contaminations. RT-qPCR products were 
analyzed in a post amplification fusion curve to ensure that a single amplicon was obtained. 
Normalization for RNA quantity, and reverse transcriptase efficiency was performed against two 
reference genes, glyceraldehyde 3- phosphate dehydrogenase (hGAPDH) and β Actin (hACTB). For 
each experimental point, 3 independent assays were carried out, each performed in triplicate. 
Relative quantification was calculated using the ΔΔCt method which was normalized to the reference 
genes. All data were analyzed by the Bio-Rad CFX Manager 3.1 software. 
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3. Results and Discussion 
 
3.1. Induction of a dopaminergic phenotype in SH-SY5Y cells 
Since uranium has potential toxicity to dopamine metabolism (Bussy 2006, Barber 2007, Briner 
2008), we chose differentiated SH-SY5Y as a representative model of human dopamine neurons to 
study uranium-related neurotoxicity. The SH-SY5Y cell line is frequently used as in vitro model of 
dopaminergic neurons (Presgraves 2004, Kovalevich 2013, Westerink 2013), in particular for metal-
induced neuronal toxicity studies (Stephenson 2013; Branca et al., 2018). However it is necessary to 
stimulate their differentiation using various agents, such as RA and TPA, into a more characteristically 
dopaminergic neuronal phenotype (Presgraves 2004, Barbosa 2014). However, culture conditions, 
cell source and differentiation protocol may vary. A recent review of the use of SH-SY5Y cells as a 
model for Parkinson's disease described the variability of these parameters in the published 
literature (Xicoy 2017). As indicated in this paper, several sources of SH-SY5Y are used. In our study, 
we compared two cell lines from (i) European Collection of Authenticated Cell Cultures (ECACC) and 
(ii) American Type Culture Collection (ATCC). The growing conditions recommended by the suppliers 
were strictly followed, and the calf serum recommended by ATCC was used exclusively for ATCC cells. 
The differentiation obtained after treatment with RA-TPA, gave satisfactory results in terms of 
neurite growth with the line from ATCC (Fig. 1) but not with that of EACC (data not shown). 
Consequently, we have selected ATCC cells for the continuation of our work. We also compared 
differentiation with RA alone (data not shown) or in combination with TPA (Fig. 1). Our results 
showed that only the combination of RA and TPA allowed to obtain an overexpression of TH, which 
confirms the results obtained by Presgraves (2004). After 7 days of differentiation, morphological and 
biochemical criteria were controlled (Fig. 1). Undifferentiated SH-SY5Y cells exhibited short neurites 
during the growth phase (Fig. 1A). After exposure to RA and TPA, an induction of extensive neurites 
outgrowth was observed (Fig. 1B). Tyrosine hydroxylase (TH) catalyzes the rate-limiting step in the 
synthesis of dopamine (DA) and other catecholamines, this makes TH the marker of choice for 
dopaminergic neurons. Therefore, change in TH, was evaluated by western blot at the end of the 
differentiation process. A significant increase in the immunocontent of TH in differentiated cells was 
observed as compared to undifferentiated cells (representative western blot in Fig. 1C). 
 
 
 
Figure 1. Induction of a dopaminergic phenotype in SH-SY5Y human cells verified by phase-contrast 
microscopy and western blot. (A) Undifferentiated control cells. Scale bar: 10 µm. (B) Differentiated 
cells showing neurite-like outgrowths after RA-TPA treatment. (C) Western blot analysis of tyrosine 
hydroxylase (TH) induction after RA-TPA treatment. Actin was used as loading control. 
 
3.2. Cell viability assays 
A RA-TPACTRL B C
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Differentiated SH-SY5Y cells were exposed to increasing concentrations of natural uranium, from 0.1 
to 1000 µM in cell culture medium and cell viability was determined by measurement of ATP content 
(Fig. 2). Cell viability assays enabled to determine the uranium concentrations that will be further 
used to study uranium subcellular distribution. Three representative concentrations were selected as 
foolowing: a non-cytotoxic concentration (10 µM), a concentration at the inflection point of the 
curve (125 µM), representing the limit of observable cytotoxic effects, and a moderately toxic 
concentration inhibiting 15% of cell viability (250 µM). 
 
 
Figure 2. ATP cytotoxicity assay following long-term exposure of differentiated SH-SY5Y cells to 
natural uranium (RLU: relative luminescence units). 
 
One of the main results of this study is that observable effects on cell viability after 7 days continuous 
exposure to natural uranium appears only at high uranium concentrations, greater than 100 µM. This 
result is in agreement with the relatively low cytotoxicity of uranium reported for various cell 
models. For example, in LLC-PK1 renal cells exposed for 24h to uranium-bicarbonate, cytotoxic 
effects were observed only for concentrations greater than 700 µM (Mirto et al., 1999). In NRK-52E 
normal renal tubular epithelial cells, the concentration leading to a 50% loss of viability was 450 µM 
for 24h exposure to uranium-bicarbonate (Carrière et al., 2004). Rouas et al. (2010) compared the 
cytotoxicity of depleted uranium on three human tumoral cell lines, HEK-293 kidney cells, Hep-G2 
liver cells, and IMR-32 neuroblastoma cells, showing in all cases that cytotoxic effects appeared only 
for exposure concentrations greater than 300 µM after either 24 or 48h. In UMR-106 osteosarcoma 
cells, a 50% loss of viability was observed after a 24h exposure to 390 µM of natural uranium 
bicarbonate (Pierrefite-Carle et al., 2016). These values have to be compared to the concentration of 
uranium in physiological fluids after normal exposure to uranium or after contamination. In normal 
individuals, uranium concentrations in the blood have been measured in the order of 5 to 10 ng.L-1  
(0.02 to 0.04 nM), and with values up to  around 100 ng.L-1 (0.4 nM) after occupational exposure 
(Byrne et al., 1991; Dang et al., 1993).  These uranium concentrations measured in human blood are 
several orders of magnitude below the first observable effects on cell viability in vitro. However, the 
low cytotoxicity of natural uranium in vitro does not exclude more subtle effects on neurological 
functions.  
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3.3. Uranium subcellular distribution 
Micro-PIXE experiments were carried out on terminally differentiated SH-SY5Y cells after long-term 
exposure to natural uranium at 0, 1, 10, 125 and 250 µM. In control cells and cells exposed to 1 µM, 
uranium content was below the limit of detection of micro-PIXE of about 1 fg per cell. Representative 
examples of intracellular uranium distribution for the other three exposure conditions are illustrated 
in Figures 3 to 5. In total, 18 cells exposed to 10 µM, 26 cells exposed to 125 µM, and 13 cells 
exposed to 250 µM were analyzed by micro-PIXE.  
The micro-PIXE combined to epifluorescence correlative microscopy approach enabled to define 
precisely the intracellular distribution of uranium in the nucleus and cytoplasm areas, respectively. 
For all uranium exposure concentrations from 10 to 250 µM, uranium is localized in the cytoplasm 
(Figures 3 to 5), and never detected in the nucleus (Figure 6). Moreover, within the cytoplasm, 
uranium is not homogeneously distributed but rather accumulates in perinuclear sub-regions of the 
cytoplasm (Figure 3 to 5), probably within intracellular organelles. Single cell analysis also reveals 
that uranium levels are surprisingly variable from one cell to another one, as illustrated in figure 4 
where the imaging of uranium in two adjacent cells shows a strong signal for the cell on the right of 
the image, and a much lower signal for the cell on the left. This inter-cellular variability is also 
exemplified by the large standard deviation found for the calculation of the mean uranium 
concentrations in single cells (Table 2). On the other hand, potassium is uniformly distributed within 
the whole cell as expected for this ubiquitous intracellular element (Figures 3 to 5). Potassium 
uniform distribution throughout the whole cell is a good marker of a correct preservation of native 
element distributions during sample preparation (Perrin et al., 2015). Potassium is present in cells as 
a highly diffusible ion, rendering its distribution very sensitive to osmotic changes during sample 
preparation that may remove it, together with other diffusible elements, out of the cells. 
 
 
 
Figure 3. Optical and micro-PIXE imaging of a single SH-SY5Y cell after long-term exposure to 10 µM 
uranium. (A) Bright field optical microscopy. (B) Epifluorescence optical microscopy of Hoechst 33542 
nuclear dye. (C) Nucleus position derived from the epifluorescence image (false color, for overlay). 
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(D) Potassium distribution. (E) Uranium distribution. (F) Overlay image of nucleus and uranium 
distribution. 
 
 
Figure 4. Optical and micro-PIXE imaging of single SH-SY5Y cells after long-term exposure to 125 µM 
uranium. (A) Bright field optical microscopy. (B) Epifluorescence optical microscopy of Hoechst 33542 
nuclear dye. (C) Nucleus position derived from the epifluorescence image (false color, for overlay). 
(D) Potassium distribution. (E) Uranium distribution. (F) Overlay image of nucleus and uranium 
distribution. 
 
 
Figure 5. Optical and micro-PIXE imaging of single SH-SY5Y cells after long-term exposure to 250 µM 
uranium. (A) Bright field optical microscopy. (B) Epifluorescence optical microscopy of Hoechst 33542 
nuclear dye. (C) Nucleus position derived from the epifluorescence image (false color, for overlay). 
(D) Potassium distribution. (E) Uranium distribution. (F) Overlay image of nucleus and uranium 
distribution. 
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Figure 6. Examples of micro-PIXE spectra from sub-cellular areas, nucleus (black line) and cytoplasm 
(red line), extracted from single cells exposed to (A) 10 µM, (B) 125 µM, and (C) 250 µM uranium. 
These spectra show that uranium is only detected within the cytoplasm, for the three exposure 
conditions. 
Previous experiments using micro-analytical methods have also reported uranium distributions in 
singles cells. The first observations were carried out by transmission electron microscopy (TEM) since 
uranium can form electron-dense precipitates easily detected by TEM. This is the case for example in 
the study of NRK-52E kidney cells cultured with high uranium concentrations, uranium electron-rich 
structures were located either inside and outside the cells (Carrière et al., 2004 and 2008). 
Intracellular and extracellular uranium precipitates were also evidenced by TEM in UMR-106 
osteosarcoma cells after 300 µM uranium exposure, but not at lower concentration, such as 100 µM 
(Pierrefite-Carle et al., 2015). In these cells, uranium precipitate was identified as meta-autunite 
using Extended X-ray Fine Structure Spectroscopy. Uranium precipitates were present in intracellular 
vesicles, such as lysosomes, multivesicular bodies or autophagosomes. In our study, we did not 
observe such intracellular precipitates probably because the exposure concentrations were below 
300 µM and the speciation of uranium in the extracellular medium was strictly controlled to avoid 
precipitation.  
The imaging of intracellular soluble forms of uranium in cells requires micro-analytical methods with 
better sensitivity than TEM. The subcellular distribution of soluble uranium could be investigated 
owing to secondary ion mass spectrometry (SIMS) imaging. Soluble uranium was detected in the 
nucleus of HepG2 liver cancer cells after exposure to 10 and 50 µM, and in the nucleus of IMR32 
neuroblastoma cells after exposure to 50 µM depleted uranium nitrate (Rouas et al., 2010). These 
results were recently confirmed by the same research group, showing that in HepG2 cells uranium 
was rapidly incorporated into the nucleus (Guéguen et al., 2015). However, a very different 
subcellular distribution of uranium was described in renal cells from a rat model of uranium-induced 
acute renal toxicity as imaged using synchrotron radiation X-ray fluorescence (SRXRF) (Homma-
Takeda et al., 2015). In this latter study, uranium was present only in the cytoplasm of the renal cells, 
while it was found in the nucleus only for few necrotic cells. Our results are in good agreement with 
the subcellular distribution of uranium described in renal cells and imaged using SRXRF. In our study, 
we did not observe uranium in the nucleus of differentiated SH-SY5Y cells, but instead uranium was 
located only in the cytoplasm for all three exposure concentrations, 10, 125 and 250 µM. Such 
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differences in uranium subcellular distribution might be explained by the denaturating conditions of 
sample preparation used for SIMS. For SIMS imaging, cells were chemically fixed with 2.5% 
glutaraldehyde, dehydrated in ethanol, and permeabilized with ethanol/epon mixture. Aldehyde 
fixation, alcohol dehydration and cell permeabilization are invasive methods known to drastically 
modify element distributions in cells, especially for soluble elements (Chjwiej et al., 2005; 
Matsuyama et al., 2009; Matysuyama et al., 2010; Hackett, et al., 2011; Roudeau et al., 2014; Perrin 
et al., 2015). Denaturating sample preparation conditions used for SIMS imaging can explain why 
uranium was not observed in the cytoplasm.  For micro-PIXE imaging, and for SXRF imaging of renal 
tissue sections (Homma-Takeda et al., 2015), samples were processed using non denaturating 
conditions. In our study, cells were processed using cryogenic protocols consisting in fast cryofixation 
and controlled freeze-drying, a methodology validated to preserve the native distribution of the 
elements (Perrin et al., 2015).  
Quantitative analysis of micro-PIXE data allowed to determine uranium content in single cells after 
exposure to the selected concentrations of natural uranium (Table 2). These results show that the 
intracellular content of uranium in the cytoplasm increased with the rise of the extracellular uranium 
concentration, but not proportionally. Intracellular uranium content was lower than the limit of 
detection (<1 fg) in control cells that were cultured in control conditions, or exposed to 1 µM of 
natural uranium. After long-term exposure to 10 µM, uranium is detected in cytoplasmic regions (34 
± 28 fg/cell), and not in the nucleus area where uranium content is below the limit of detection (<1 
fg). After long-term exposure to 125 µM, uranium content increases considerably in the cytoplasm 
(1297 ± 1523 fg/cell), with a 38 fold rise of the cytoplasmic content consequently to the exposure to 
extracellular uranium concentration 12.5 times higher(from 10 µM to 125 µM). Then after long-term 
exposure to 250 µM U, a 1.5 fold rise of uranium intracellular content is measured (1908 ± 1207 
fg/cell) compared to the 125 µM U exposure, roughly proportional to the increase of extracellular 
content by a factor two Our …. These results suggest a two-steps uptake of uranium. At 10 µM 
uranium exposure, a non cytotoxic concentration (Fig. 2), the intracellular uranium content is very 
low. This result reflects a correct function of cellular mechanisms of defense through restrained 
uptake, efficient efflux, or both mechanisms. At higher exposure concentrations, the cellular 
mechanisms responsible for uranium uptake seem to be overwhelmed, resulting in much higher 
intracellular content. This two-steps behavior for uranium intracellular accumulation, after low or 
high exposure conditions, can be attributed to the activation of different uptake pathways as also 
suggested for intracellular uranium isotopic fractionation studies (Paredes et al., 2016). 
Another striking result of the quantitative analysis of the data is the high inter-cellular variability of 
uranium content, as illustrated by the large standard deviation of the mean observed for all three 
exposure conditions (Table 2). This observation is very well illustrated by the very different uranium 
contents in two adjacent cells from the same sample (Fig. 4). These results seem to be rather 
unexpected considering that SH-SY5Y cells were fully differentiated and should therefore represent a 
quite uniform population in terms of protein expression profile. Also, since cells were exposed to 
uranium for a long period of time, 7 days, one could expect that all the cells would reach a stable and 
comparable intracellular uranium content. One explanation of these heterogeneous contents could 
be that the differentiation protocol led to heterogeneous phenotypes at the single cell level, 
although when measuring the average effect of differentiation it results in the expression of the 
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dopaminergic phenotype. This variability has probably multiple origins that are difficult to explain 
with our data, however, identifying these origins would bring valuable information to understand the 
molecular mechanisms involved in the modulation of cell susceptibility to uranium uptake and 
toxicity. 
 
 
U exposure 
(µM) 
U content in the cytoplasm / cell  
(fg ± SD) 
0 < LOD (n=8) 
1 < LOD (n=5) 
10  34 ± 28 (n=18) 
125  1297 ± 1523  (n=26) 
250  1908 ± 1207 (n=13) 
 
Table 2. Uranium content in the cytoplasmic area of single differentiated SH-SY5Y cells after long-
term exposure to 10, 125, and 250 µM of natural uranium (LOD: limit of detection = 1 fg). 
 
3.4. Modulation of genes related to neurological functions after uranium exposure 
Using real-time quantitative RT-PCR analysis, the expression of genes related to catecholaminergic 
pathways was studied in uranium-treated SH-SY5Y cells and compared with unexposed cells (Table 
3). Treatment with 10, 125 or 250 µM uranium significantly decreased the expression of Monoamine 
Oxidase B (MAOB) gene in a dose-dependent manner (P < 0.05), the fold changes being respectively -
1.8, -4.1 and -5.1. Tyrosine hydroxylase (TH) gene expression was also decreased, although the 
difference was statistically significant only after 10 µM exposure. VMAT2 vesicular monoamine 
transporter 2 (SLC18A2 / VMAT2), Dopa decarboxylase (DDC), and dopamine receptor D1 (DRD1) 
gene expression were not modified upon uranium exposure or not statistically significantly. The 
signals obtained for DAT dopamine transporter (SLC6A3) and dopamine receptor D3 (DRD3) were too 
low to be detected.  
 
Gene Name Function 
U 
10 µM 
U 
125 µM 
U 
250 µM 
DDC 
Dopa  
decarboxylase 
Biosynthesis of 
dopamine 
-1.2 1 1.4 
DRD1 
D1 subunit of 
dopamine receptor  
Dopamine receptor 
-3.2 1.1 -1.5 
DRD3 
D3 subunit of 
dopamine receptor  
Dopamine receptor 
ND ND ND 
MAO-B 
Monoamine 
oxidase B 
Catabolism of 
monoamines 
-1.8* -4.1* -5.1* 
SLC18A2 / 
VMAT2 
VMAT2 Vesicular 
Monoamine 
Transport of 
monoamines 
1.3 1.4 1.4 
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Transporter 2 neurotransmitters  
SLC6A3 / DAT 
DAT Dopamine 
transporter 
Dopamine transport 
ND ND ND 
TH 
Tyrosine 
hydroxylase 
Biosynthesis of 
dopamine 
-3.7* -1.2 -3.1 
 
Table 3. RT-Q-PCR analysis of genes involved in catecholaminergic pathways of differentiated SHSY-
5Y cells after 7 days continuous exposure to 10, 125 and 250 µM natural uranium. Gene expression 
was compared to the respective untreated control. The expression levels of the target gene were 
normalized to the expression level of ACTB (beta actin) and GAPDH (Glyceraldehyde-3-Phosphate 
Dehydrogenase). * P-value < 0.05; ND: not detected. 
 
Animal studies have shown that exposure to uranium can affect neurotransmitter pathways, in 
particular the cholinergic and monoamine systems (Bussy et al., 2006; Barber et al., 2007; Briner et 
al., 2008; Bensoussan et al., 2009; Dinocourt et al., 2015). For instance, acetylcholinesterase activity 
and monoamine metabolism were found to be disturbed in male rat brains after long-term chronic 
exposure to uranyl nitrate in drinking water (Bussy et al., 2006). In this study, acetylcholinesterase 
activity was transitionally perturbed in the cerebellum after 6 months of exposure but was 
unaffected in the striatum, hippocampus and frontal cortex. More pronounced effects were 
observed on monomamine metabolism in this same study. After 1.5 months of uranium exposure, 
dopamine level increased in the hypothalamus but not in other brain regions such as the striatum. 
After 9 months of exposure, a significant decrease of DOPAC (3,4-dihydroxyphenylacetic acid) was 
observed in the striatum, while dopamine and other monoamines and dopamine metabolites were 
unchanged. Our results, showing a decrease of MAO-B gene expression in dopaminergic cells 
exposed to uranium (Table 3) could explain the reported decrease of DOPAC level in the striatum 
after uranium exposure in rats through drinking water. Since dopamine is transformed into its 
metabolite DOPAC through MAO catalyzed deamination, depletion of MAO-B expression could result 
in DOPAC decrease. Both studies point out the specific sensitivity of dopamine catabolism pathway 
to uranium exposure. The finding of a specific MAO-B alteration following exposure to uranium can 
also be compared to the ones described for other neurotoxic metals. For example, exposure to 
manganese chloride can induce the decrease in the expression of MAO in mitochondria from rat 
brains (Zhang et al., 2003). Lead is another neurotoxic metal known to cause the decrease in MAO 
levels in animal models (Jaya Prasanthi et al., 2005; Chand Basha et al., 2014). Deficit of MAO-B have 
been associated to a broad range of neurological disorders such as psychotic disorders, depression, 
alcoholism, impulsivity, and neurodegenerative diseases (Bortolato et al., 2011). 
The reported results on brain dopamine content of animal models exposed to uranium are however 
variable (Bussy et al., 2006; Barber et al., 2007; Briner et al., 2008). As previously mentioned, 
dopamine levels were unchanged in all brain regions after chronic exposure to depleted uranium at 
1.5, 6 and 9 months exposure (Bussy et al., 2006). In another study, striatal dopamine content was 
reduced by 30% three days after intramuscular injection of 1 mg/kg of uranyl acetate but returned to 
control levels after 7 days (Barber et al., 2007). This acute exposure to uranium through 
intramuscular injection did not modify DOPAC levels in the striatum. In a 2-week study in mice 
exposed to 6 mg U/kg/day (depleted uranyl acetate), exposure to uranium significantly increased 
tyrosine and decreased 3,4-dihydroxyphenylalanine (DOPA), norepinephrine, and epinephrine; but 
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had no significant effect on dopamine or homovanillic acid (Briner 2008). In our study, TH gene 
expression was statistically significantly reduced after 7 days exposure to 10 µM uranium. Overall 
these results suggest that uranium exposure alters the dopaminergic system but with different 
outcomes, probably reflecting differences in exposure conditions and the complexity of the uranium 
interaction with the dopaminergic system. 
 
4. Conclusions 
It is known from the literature that uranium exposure results in uranium circulating in the blood 
which will reach the brain causing neurological impairments. However too few data have been 
published to evaluate the thresholds of exposure and observable neurological effects and the 
molecular mechanisms involved in uranium neurotoxicity. In this study we have shown that after7 
day exposure to natural uranium of dopaminergic cells a low cytotoxicity was observed. Toxic 
concentrations were greater than 100 µM, far from the expected uranium concentrations in blood 
even after occupational exposure (< 1 µM). The low uranium cytotoxicity can be explained by the 
limited cellular uptake of uranium, especially at low exposure concentration since this element was 
below the limit of detection (< 1 fg) in cells exposed to 1 µM uranium during 7 days, and detected in 
low content (34 fg / cell) after exposure to the non toxic concentration of 10 µM . The cytotoxicity 
effects only occurred for exposure concentrations higher than 100 µM when uranium was detected 
in significant amount in cells (> 1000 fg / cell). Our results also suggest a differential cellular uptake of 
uranium after low or high uranium exposure. At low uranium exposure (1 and 10 µM), a very limited 
uranium incorporation is observed suggesting a controlled mechanism of uptake and efflux, while at 
high uranium exposure (100 and 250 µM) this controlled mechanism is less effective resulting in 
relatively high uranium intracellular concentrations. Another major result obtained in this study is 
that whatever the exposure concentration, up to 250 µM during 7 days exposure, uranium was under 
the detection limit in the nucleus of differentiated SH-SY5Y cells suggesting that uranium toxicity is 
not induced by direct interaction with genomic DNA. Uranium was found only in the cytoplasm, 
restricted to perinuclear sub-regions suggesting organelle’s confinement yet to be determined. This 
cytoplasmic perinuclear distribution of uranium might reflect interaction with the secretory pathway. 
An intriguing result of this study is the observed high inter-cellular variability with cells having not 
incorporated almost any uranium even at high exposure conditions during 7 days. Although this 
result is difficult to understand with the available data it highlights the importance of single cell 
analysis experiments. This intercellular variability in uranium uptake may reflect differences in cell 
differentiation at the single cell level, and/or other individual phenotypes which are critical in 
uranium uptake and subsequent toxicity. Although uranium was cytotoxic only at high 
concentrations (> 100 µM), some modifications of expression in genes involved in monoamine 
metabolism were detected after 10 µM exposure. The main result was obtained for gene expression 
of monoamine oxidase B, being statistically significantly reduced after 10, 125 and 250 µM uranium 
exposure. This result might explain why DOPAC is decreased in rats chronically exposed to uranium in 
drinking water (Bussy et al., 2006). This last study and ours indicate that the catabolism of dopamine 
could be a critical target of uranium neurotoxicity. Further analyses are now required to better 
understand if low uranium exposure can interact with the secretory pathway in dopaminergic cells 
and with the monoamine oxidase protein expression. 
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